Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

Conditions: Hemophilia; Hemorrhage; Facelift Surgery Interventions: Drug: 1%Tranexamic acid with standard local; Drug: 3% TXA; Drug: 1% TXA with local plus 3% TXA-soaked pledgets Sponsors: University of Minnesota Not yet recruiting

https://clinicaltrials.gov/study/NCT06345833

Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials